top of page
  • Writer's pictureBema Yeo

Miracle Weight Loss - More than 1 Billion People Clinically Obese Worldwide

According to a World Health Organization report from 2022, obesity has increased by almost threefold since 1975 and it is still on the rise. Globally, it has been reported that more than 1 billion people are clinically obese, and that include 650 million adults, 340 million

teenagers, and 39 million children. Obesity is a major risk factor for chronic diseases such as diabetes, cardiovascular disease, and some cancers. The report highlights the urgent need for governments to implement policies that promote healthy eating habits and physical activity to tackle this global health issue and some providers are seeking to get Wegovy approved.

Wegovy is one of several new “miracle” drugs that promise to revolutionize the weight-loss industry and it is praised by celebrities and social media influencers. The FDA recently approved Wegovy (semaglutide), a GLP-1 receptor agonist, as a weight loss treatment for teens ages 12 and up. Wegovy is now the first once-weekly weight loss drug approved for adolescents. Wegovy has already been approved for adults and has shown significant weight loss results. The drug works by reducing appetite and increasing feelings of fullness, leading to a decrease in calorie intake.

Wegovy Injection - The hidden Miracle Weight Loss Injection

Wegovy, also known by its generic name semaglutide, is a prescription medication used for weight management in adults with obesity or overweight and at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol. It is administered as a weekly injection and works by mimicking a naturally occurring hormone in the body that regulates appetite and food intake. Clinical trials have shown that patients who took Wegovy lost significantly more weight than those who took a placebo. However, it is important to note that this medication should be used in conjunction with a healthy diet and exercise program for optimal results.



Is Wegovy FDA Approved?

Wegovy was approved by the U.S. Food and Drug Administration (FDA) in June 2021, following clinical trials that showed significant weight loss results in participants. It is a weight loss drug manufactured by Danish pharmaceutical company Novo Nordisk. NICE has issued guidelines recommending Wegovy be prescribed to people who have a particular BMI (usually 30kg/m2 and over) and at least one weight-related health conditionAccording to the manufacturer, Novo Nordisk, individuals taking Wegovy in combination with a reduced-calorie diet and increased physical activity lost an average of 15% of their body weight after one year, compared to those on a placebo.


Like any medication, Wegovy is not suitable for everyone and may have potential side effects. It should only be taken under the guidance and supervision of a healthcare professional, who can assess an individual's medical history, current health status, and other factors to determine if it is a safe and appropriate treatment option. Additionally, weight loss medications like Wegovy should be used as part of a comprehensive weight management plan that includes healthy lifestyle changes, such as a balanced diet and regular exercise.


Weight loss injections have become an increasingly popular method for individuals seeking to lose weight quickly and efficiently. These injections typically contain a combination of vitamins, amino acids, and other nutrients that are believed to promote weight loss by increasing metabolism and reducing appetite. While weight loss injections may seem like an easy solution to shedding unwanted pounds, it is important to note that they are not as a miracle cure and should be used in combination with a healthy diet and regular exercise to achieve optimal results. Additionally, weight loss injections should only be used under the guidance and supervision of a healthcare professional, as there may be potential side effects and risks associated with their use.


How does Wegovy Injection Cost?

The cost of Wegovy can vary depending on factors such as location, insurance coverage

, and the dosage prescribed. According to the manufacturer, Novo Nordisk, the list price for a four-week supply of Wegovy is $1,306.20, which is equivalent to $327 per weekly injection. However, it is important to note that the actual cost to an individual may be lower or higher, as insurance plans and other discounts may be available to help reduce the out-of-pocket cost. It is recommended to speak with a healthcare provider and/or pharmacist, as well as the individual's insurance provider, to determine the cost of Wegovy and any potential financial assistance options that may be available.


What are the Side Effects of Wegovy?

Wegovy is a new medication, there may be other potential side effects that are not yet known. As with any medication, Wegovy (semaglutide) may cause side effects and it is highly recommended to seek immediate medical attention if any of these symptoms occur. Some of the most common side effects reported in clinical trials include:

  • Nausea

  • Diarrhea

  • Vomiting

  • Constipation

  • Stomach pain

  • Headache

  • Fatigue

These side effects are generally mild and may improve over time as the body adjusts to the medication. However, if they persist or become severe, it is important to consult a healthcare provider.

Less common but potentially serious side effects of Wegovy may include:

  • Acute gallbladder disease

  • Pancreatitis

  • Hypoglycemia (low blood sugar)

  • Acute kidney injury

Is Wegovy effective?

Based on some research and reviews from patients, some people believe that Wegovy (semaglutide) has been shown to be effective in clinical trials for weight management in adults with obesity or overweight and at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol.It is recommended that in clinical trials, individuals must be taking Wegovy in combination with a reduced-calorie diet and increased physical activity lost an average of 15% of their body weight after one year, compared to those on a placebo.


This weight loss was sustained over a longer period, with participants maintaining an

average weight loss of 12-14% after two years of treatment. Additionally, individuals taking Wegovy experienced improvements in other health markers, such as reductions in blood pressure, blood sugar levels, and cholesterol levels. Like any other weight loss medications, Wegovy are not a substitute for healthy lifestyle changes, such as a balanced diet and regular exercise. They should be used as part of a comprehensive weight management plan under the guidance and supervision of a healthcare professional.


What Else Miracle Weight Loss Medications are out There?

Wegovy (semaglutide) is a relatively new medication for weight management, and as such, there are currently few direct competitors available in the market. However, there are other medications that have been approved for weight loss or that are commonly used off-label for this purpose, and they may be considered as potential alternatives or complementary treatments to Wegovy. Some of these medications include:

  • Orlistat (Xenical, Alli): Orlistat is a medication that blocks the absorption of dietary fat in the body, leading to weight loss. It is available over-the-counter (Alli) or by prescription (Xenical).

  • Phentermine/topiramate (Qsymia): This medication combines an appetite suppressant (phentermine) with an anti-seizure medication (topiramate) and has been shown to promote weight loss in clinical trials.

  • Liraglutide (Saxenda): Like semaglutide, liraglutide is a medication that mimics a naturally occurring hormone in the body and is used for weight management. It is also administered as a weekly injection.


Conclusion

Weight loss medications, including Wegovy (semaglutide), can be a useful tool in the treatment of obesity and overweight, especially when used as part of a comprehensive weight management plan that includes lifestyle changes such as a healthy diet and regular exercise. Clinical studies have shown that Wegovy is effective in promoting weight loss and improving other health markers in adults with obesity or overweight and at least one weight-related condition.


However, like any medication, there are potential side effects and risks associated with the

Weight loss

use of weight loss medications, and they should be used only under the guidance and supervision of a healthcare professional. It is also important to note that weight loss medications should not be considered a substitute for healthy lifestyle changes and are most effective when used in combination with such changes.


Individuals considering weight loss medications should discuss their options with a healthcare provider, and should also be prepared to commit to long-term changes in their diet and exercise habits to achieve and maintain a healthy weight. By working with a healthcare provider and making positive lifestyle changes, individuals can achieve their weight loss goals and improve their overall health and well-being.






Comments


bottom of page